Continue to Site »
Site will load in 15 seconds
Advertisment: OHP » OHP Order 112 » CBT ROS Banner 970x250 August 2025 » ohp-april-botanigard

Trump’s Forthcoming Rescheduling Decision, Congressman’s Marijuana 1-to-3 Act Lead CBT’s Top Stories in August

President Donald Trump said his decision on whether to change cannabis’s control status will come in the ‘next few weeks.’

Top10 August2025
Adobe Stock | YARphotographer

Tony Headshot

President Donald Trump’s recent comments on cannabis rescheduling landed as the top trending storyline that Cannabis Business Times’ readers did not want to miss out on this month.

Nearly seven months after his inauguration, Trump broke his silence on the cannabis reform topic during a White House press conference on Aug. 11, when he told reporters “we’re looking at that,” and “we’ll make a determination … over the next few weeks.”

Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies 2026 ROS Parallax Reveal » bcc-ads-730x570
Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies 2026 ROS Parallax Reveal » bcc-ads-730x570

Trump turned around and looked at Attorney General Pam Bondi when he mentioned the timeframe for the determination on whether to move forward with a proposed rule to reclassify cannabis from a Schedule I to Schedule III drug under the Controlled Substances Act.

Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies ROS 300x250 Medium Rectangle » great-place-2026-animation300x250.gif

The current rescheduling hearing process, ignited under President Joe Biden, was stayed by a now-retired administrative law judge in early January and has been pending the resolution of an interlocutory appeal since.

Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies ROS 300x250 Medium Rectangle » great-place-2026-animation300x250.gif

The Trump administration could decide to resume the hearing process under a new Drug Enforcement Administration (DEA) administrative law judge, move forward on the current proposed rule without the hearing process by fast-tracking straight to a final rule, start from square one with a new scientific and medical review under the U.S. Department of Health and Human Services, or just scrap the reform package altogether.

Taking the No. 2 spot in CBT’s Top 10 most-read articles this month was a piece on U.S. House Rep. Greg Steube, R-Fla., filing legislation to reclassify cannabis to a Schedule III substance—the Marijuana 1-to-3 Act—the day after Trump’s comments.

Advertisment: Emerald Harvest » Emerald Harvest Order 115 » CBT ROS Leaderboard Ad 728x90 August 2025 » eh-360-web-banner-728x90.

“It makes zero sense that federal law treats marijuana the same as heroin and LSD,” Steube said. “It is even more ridiculous that cocaine is technically classified as less restrictive than marijuana.”

Other articles that readers did not want to miss out on in August included those on the Texas Senate passing another hemp THC ban bill in a second special session, AYR Wellness’ Massachusetts exit, and a well-known lawyer bringing to light that he alerted New York cannabis regulators more than a year ago that they were erroneously measuring buffer zones between dispensaries and schools.

Don’t miss out on our Top 10 stories from August 2025.

Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies ROS 300x250 Medium Rectangle » great-place-2026-animation300x250.gif
Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies ROS 300x250 Medium Rectangle » great-place-2026-animation300x250.gif
Page 1 of 13
Next Page
Advertisment: Fluence » Fluence Order 95 » CBT ROS Mobile Adhesion 360x120 August 2025 » FLU-DBA_INSA_360-x-120